Vaccine Scheduler

Luxembourg: Recommended vaccinations

	General recommendation
	Recommendation for specific groups only
	Catch-up (e.g. if previous doses missed)
	Vaccination not funded by the National Health system
	Mandatory vaccination

	Birth	Months							Years
	Birth	2	3	4	12	13	14	15-23	5-6	9	12	13	14	15-16	17	18	60-64	≥ 65
Coronavirus disease (COVID-19)¹									COVID-19²

rotavirus infection		ROTA	ROTA

diphtheria		D	D	D		D			D					d³
tetanus		TT	TT	TT		TT			TT					TT³
pertussis		acP	acP	acP		acP			acP					acP³
poliomyelitis		IPV	IPV	IPV		IPV			IPV					IPV³
Haemophilus influenzae type b infection		Hib	Hib	Hib		Hib
hepatitis B	HepB⁴	HepB	HepB			HepB					HepB⁵

pneumococcal disease		PCV		PCV	PCV				PCV								PPSV23⁶	PCV13+PPSV23⁶

meningococcal disease			MenB⁷			MenC	MenB⁷							MenC⁸	MenB⁷

measles					MEAS			MEAS								MEAS⁹
mumps					MUMPS			MUMPS								MUMPS⁹
rubella					RUBE			RUBE								RUBE⁹

varicella					VAR			VAR

human papillomavirus infection										HPV (F/M)¹⁰			HPV (F/M)¹¹

influenza																		IIV4

Version:

Footnotes:

https://sante.public.lu/fr/actualites/2020/12/communique-strategie-vaccination/index.html
https://sante.public.lu/fr/actualites/2020/12/communique-strategie-vaccination/index.html https://covid19.public.lu/dam-assets/covid-19/documents/strategie-vaccinale/CSMI-avis-priorisation-vaccin-COVID-19-phases-2-et-suivantes-20210127.pdf
Subsequent Tdacp-IPV booster every 10 years
Babies born to a mother infected with hepatitis B will be offered a first dose at birth
if no history of vaccination
It is recommended that populations at risk and elderly 65 years of age and over receive a dose of 13-valent pneumococcal conjugate vaccine (PCV13) followed, 8 weeks later, by a dose of 23-valent pneumococcal polysaccharide vaccine (PCV23). In the present state of knowledge, the CSMI recommends a PPV23 recall only in people at risk, who are recalled every 5 years. Children at risk of invasive pneumococcal infection are also affected by this recommendation: in the absence of previous vaccination with PCV13, catch-up is indicated. For mopre informeation: http://www.sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/infection-pneumocoques/index.html
Two/three doses recommended in at-risk groups, depending on age. Further information available at: http://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite/2018-avis-vaccination-meningocoque-groupe-b.pdf
see http://sante.public.lu/fr/espace-professionnel/recommandations/conseil-maladies-infectieuses/meningite/2018-vaccination-meningocoque-c.pdf
Given the resurgence of measles, all adults born after 1980 who have not received two doses of measles, mumps and rubella vaccines should recall the MMR vaccine
9-valent. Gender-neutral (boys and girls) vaccination offered. Two doses with 6 months interval
Three doses

More information available at:
http://www.sante.public.lu/fr/prevention/vaccination/index.html

-------------------------------------------------------------------------------------------------------------------------

ADDITIONAL COMMENT
All infant vaccinations in Luxembourg are given free of charge. All subsequent adult vaccinations are not free of charge.

MAJOR HISTORICAL CHANGES
1986: The combined MMR vaccine was introduced in the national childhood vaccination schedule and recommended at 15-18 months of age
1994: The second MMR dose was introduced in the national childhood vaccination schedule and recommended at 5-7 years
2008: March 2008. HPV vaccination was introduced in the national childhood vaccination schedule for females aged 12 years with a catch-up programme up to 18 years of age
2018: MenC 2nd dose introduced at 15-16 years; MenB introduced for increased risk groups

Date of last update: 16 Dec 2020

-------------------------------------------------------------------------------------------------------------------------